Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease.

Xiao-Yu LiangFen-Fang HongShu-Long Yang

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)

ASIV may reduce liver steatosis, hepatocyte oxidative stress and apoptosis, and decrease liver inflammation, thereby attenuating the progression of NAFLD and thus might be of therapeutic interest.

Keyphrases

oxidative stress
diabetic rats
ischemia reperfusion injury
dna damage
induced apoptosis
insulin resistance
high fat diet
cell death
cell proliferation
mouse model
adipose tissue